Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation?

Transplantation

Volumn 84, Issue 11, 2007, Pages 1406-1412

  Huo, Samantha C ^a,b   Huo, Teh Ia ^a,c   Lin, Han Chieh ^a,c   Chi, Chin Wen ^a,c   Lee, Pui Ching ^a   Tseng, Fan Wei ^c   Lee, Shou Dong ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b WASHINGTON UNIVERSITY   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Creatinine; Liver cirrhosis; Liver transplantation; MELD

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORRECTED CREATININE MODEL FOR END STAGE LIVER DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN ALLOCATION; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CREATININE; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SEX CHARACTERISTICS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT;

EID: 37349019418     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000282867.92367.d0     Document Type: Article

References (25)

1. Wiesner R, Edwards E, Freeman R, et al. United Network For Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
2. Olthoff KM, Brown RS Jr., Delmonico FL, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10: A6.
3. Freeman RB, Wiesner RH, Edwards E, et al. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7.
4. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52: 134.
5. de la Mata M, Cuende N, Huet J, et al. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a Spanish multicenter experience. Transplantation 2006; 82: 1429.
6. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36: 494.
7. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores - a systematic bias. Am J Transplant 2007; 7: 685.
8. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998; 66: 956.
9. Huo TI, Lin HC, Wu JC, et al. Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction. Transplantation 2005; 80: 1414.
10. Lamb EJ, Tomson CR, Roderick PJ. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42: 321.
11. Poggio ED, Wang X, Greene T, et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459.
12. Gonwa TA, Jennings L, Mai ML, et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transpl 2004; 10: 301.
13. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247.
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29.
15. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839.
16. Freeman RB Jr., Wiesner RH, Roberts JP, et al. Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4 Suppl 9: 114.
17. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897.
18. Huo TI, Huang YH, Lin HC, et al. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol 2006; 101: 975.
19. Huo TI, Lin HC, Huang YH, et al. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing loco-regional therapy. Cancer 2006; 107: 141.
20. Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006; 20: 188.
21. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003; 98: 1395.
22. Huo TI, Wu JC, Lee SD. MELD in liver transplantation: the da Vinci code for the Holy Grail? J Hepatol 2005; 42: 477.
23. Ravaioli M, Masetti M, Ridolfi L, et al. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation 2007; 83: 919.
24. Kanwal F, Dulai G, Gralnek I, et al. The impact of gender on access to liver transplantation in the MELD era. Gastroenterology 2005; 128: A701.
25. Chan HL, Chim AM, Lau JT, et al. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol 2006; 101: 1516.